{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:11:21Z","timestamp":1791994281886,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["tipsro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Technical Innovations &amp; Patient Support in Radiation Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.tipsro.2023.100230","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T12:02:25Z","timestamp":1702468945000},"page":"100230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploring patient-reported barriers to participating in proton therapy clinical trials"],"prefix":"10.1016","volume":"29","author":[{"given":"Anne","family":"Wilh\u00f8ft Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annesofie","family":"Lunde Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Oksbjerre Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"Friborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3548-3527","authenticated-orcid":false,"given":"Cai","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tipsro.2023.100230_b0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and Neck Cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tipsro.2023.100230_b0010","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2016.02.044","article-title":"Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes","volume":"95","author":"Sio","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.tipsro.2023.100230_b0015","article-title":"Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy","volume":"47","author":"Friborg","year":"2023","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.tipsro.2023.100230_b0020","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.oraloncology.2011.05.012","article-title":"The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy","volume":"47","author":"Ramaekers","year":"2011","journal-title":"Oral Oncol"},{"issue":"6\u20137","key":"10.1016\/j.tipsro.2023.100230_b0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.canrad.2020.05.002","article-title":"Proton therapy and the European Particle Therapy Network: The past, present and future","volume":"24","author":"Weber","year":"2020","journal-title":"CancerRadiother"},{"key":"10.1016\/j.tipsro.2023.100230_b0030","unstructured":"Xingzhe Li AL, MAC, EJS, NYL. Past, present and future of proton therapy for head and neck cancer. Oral Oncology. 2020."},{"issue":"5","key":"10.1016\/j.tipsro.2023.100230_b0035","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/0284186X.2014.998279","article-title":"Socioeconomic position and stage at diagnosis of head and neck cancer - a nationwide study from DAHANCA","volume":"54","author":"Olsen","year":"2015","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.tipsro.2023.100230_b0040","first-page":"137","article-title":"Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study","volume":"2","author":"Unger","year":"2016","journal-title":"JAMAOncol"},{"issue":"13","key":"10.1016\/j.tipsro.2023.100230_b0045","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1200\/JCO.18.01983","article-title":"Socioeconomic Differences in Referral to Phase I Cancer Clinical Trials: A Danish Matched Cancer Case-Control Study","volume":"37","author":"Gad","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.tipsro.2023.100230_b0050","doi-asserted-by":"crossref","first-page":"e056294","DOI":"10.1136\/bmjopen-2021-056294","article-title":"Definitions and measurement of health literacy in health and medicine research: a systematic review","volume":"12","author":"Urstad","year":"2022","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.tipsro.2023.100230_b0055","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.3390\/curroncol29050253","article-title":"Health Literacy and Clinical Trial Participation in French Cancer Patients: A National Survey","volume":"29","author":"Ousseine","year":"2022","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.tipsro.2023.100230_b0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12874-021-01478-5","article-title":"Oncologic patients' misconceptions may impede enrollment into clinical trials: a cross-sectional study","volume":"22","author":"Asher","year":"2022","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.tipsro.2023.100230_b0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11764-015-0471-x","article-title":"Do we reach the patients with the most problems? Baseline data from the WebCan study among survivors of head-and-neck cancer","volume":"10","author":"Kjaer","year":"2016","journal-title":"Denmark J Cancer Surviv"},{"issue":"3","key":"10.1016\/j.tipsro.2023.100230_b0070","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.3747\/co.20.1323","article-title":"A comparison of patient knowledge of clinical trials and trialist priorities","volume":"20","author":"Cameron","year":"2013","journal-title":"Curr Oncol"},{"issue":"7","key":"10.1016\/j.tipsro.2023.100230_b0075","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/bjc.2013.113","article-title":"Drivers and barriers to patient participation in RCTs","volume":"108","author":"Jenkins","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.tipsro.2023.100230_b0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/EDBK_156686","article-title":"The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies","volume":"35","author":"Unger","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"10.1016\/j.tipsro.2023.100230_b0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/djy221","article-title":"Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation","volume":"111","author":"Unger","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.tipsro.2023.100230_b0090","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/jnci\/djaa155","article-title":"\u201cWhen Offered to Participate\u201d: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials","volume":"113","author":"Unger","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.tipsro.2023.100230_b0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1200\/EDBK_243729","article-title":"Overcoming Barriers to Clinical Trial Enrollment","volume":"39","author":"Nipp","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.tipsro.2023.100230_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2021.100829","article-title":"Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews","volume":"23","author":"Rodriguez-Torres","year":"2021","journal-title":"Contemp Clin Trials Commun"},{"issue":"1","key":"10.1016\/j.tipsro.2023.100230_b0105","first-page":"78","article-title":"Older adult participation in cancer clinical trials: A systematic review of barriers and interventions","volume":"71","author":"Sedrak","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.tipsro.2023.100230_b0110","doi-asserted-by":"crossref","unstructured":"Thijssen SV, Boersma LJ, Heising L, Swart RR, C XJO, Roumen C, et al. Clues to address barriers for access to proton therapy in the Netherlands. Radiother Oncol. 2022.","DOI":"10.1016\/j.radonc.2022.11.021"},{"issue":"9","key":"10.1016\/j.tipsro.2023.100230_b0115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1200\/OP.22.00122","article-title":"The road less traveled: transportation barriers to cancer care delivery in the rural patient population","volume":"18","author":"Wercholuk","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"10","key":"10.1016\/j.tipsro.2023.100230_b0120","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/imj.14456","article-title":"Results of a survey of cancer patients' willingness to travel to participate in a clinical trial","volume":"49","author":"Zdenkowski","year":"2019","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.tipsro.2023.100230_b0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1098-240X(199704)20:2<169::AID-NUR9>3.0.CO;2-I","article-title":"Interpretive description: a noncategorical qualitative alternative for developing nursing knowledge","volume":"20","author":"Thorne","year":"1997","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.tipsro.2023.100230_b0130","unstructured":"Thorne SE. Interpretive Description, Qualitative Research for Applied Practice. 2016:336."},{"issue":"20","key":"10.1016\/j.tipsro.2023.100230_b0135","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association Declaration of Helsinki","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.tipsro.2023.100230_b0140","unstructured":"Sundhedsstyrelsen. Pakkeforl\u00f8b for hoved-halskr\u00e6ft. 2020."},{"issue":"13","key":"10.1016\/j.tipsro.2023.100230_b0145","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample Size in Qualitative Interview Studies: Guided by Information Power","volume":"26","author":"Malterud","year":"2016","journal-title":"Qual Health Res"},{"key":"10.1016\/j.tipsro.2023.100230_b0150","series-title":"Qualitative data analysis with NVivo","author":"Bazeley","year":"2019"},{"issue":"9","key":"10.1016\/j.tipsro.2023.100230_b0155","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/pon.3795","article-title":"Conceptual analysis of suffering in cancer: a systematic review","volume":"24","author":"Best","year":"2015","journal-title":"Psychooncology"},{"issue":"2","key":"10.1016\/j.tipsro.2023.100230_b0160","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/scs.12637","article-title":"What matters in clinical trial decision-making: a systematic review of interviews exploring cancer patients' experiences","volume":"33","author":"Gregersen","year":"2019","journal-title":"Scand J Caring Sci"},{"issue":"1","key":"10.1016\/j.tipsro.2023.100230_b0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12874-018-0614-7","article-title":"The challenges of recruiting cancer patient\/caregiver dyads: informing randomized controlled trials","volume":"18","author":"Heckel","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"10.1016\/j.tipsro.2023.100230_b0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/hir.12325","article-title":"Finding useful cancer information may reduce cancer information overload for Internet users","volume":"37","author":"Ser\u00e7eku\u015f","year":"2020","journal-title":"Health Info Libr J"},{"issue":"3","key":"10.1016\/j.tipsro.2023.100230_b0175","first-page":"516","article-title":"Differences in trial knowledge and motives for participation among cancer patients in phase 3 clinical trials","volume":"25","author":"Godskesen","year":"2016","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"4","key":"10.1016\/j.tipsro.2023.100230_b0180","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ijrobp.2015.12.020","article-title":"Distance to Radiation Facility and Treatment Choice in Early-Stage Breast Cancer","volume":"94","author":"Acharya","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.tipsro.2023.100230_b0185","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/cncr.31190","article-title":"Travel distance and stereotactic body radiotherapy for localized prostate cancer","volume":"124","author":"Mahal","year":"2018","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.tipsro.2023.100230_b0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijrobp.2016.05.022","article-title":"Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?","volume":"96","author":"Muralidhar","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.tipsro.2023.100230_b0195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1740774510392257","article-title":"Personal benefit, or benefiting others? Deciding whether to take part in clinical trials","volume":"8","author":"Locock","year":"2011","journal-title":"Clin Trials"},{"issue":"1","key":"10.1016\/j.tipsro.2023.100230_b0200","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13063-017-2099-9","article-title":"Barriers to the conduct of randomised clinical trials within all disease areas","volume":"18","author":"Djurisic","year":"2017","journal-title":"Trials"},{"issue":"1S","key":"10.1016\/j.tipsro.2023.100230_b0205","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.chest.2020.03.013","article-title":"Randomized Controlled Trials","volume":"158","author":"Zabor","year":"2020","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.tipsro.2023.100230_b0210","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/jan.13031","article-title":"Systematic methodological review: developing a framework for a qualitative semi-structured interview guide","volume":"72","author":"Kallio","year":"2016","journal-title":"J Adv Nurs"}],"container-title":["Technical Innovations &amp; Patient Support in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632423000306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632423000306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:17:32Z","timestamp":1762503452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405632423000306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"alternative-id":["S2405632423000306"],"URL":"https:\/\/doi.org\/10.1016\/j.tipsro.2023.100230","relation":{},"ISSN":["2405-6324"],"issn-type":[{"value":"2405-6324","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring patient-reported barriers to participating in proton therapy clinical trials","name":"articletitle","label":"Article Title"},{"value":"Technical Innovations & Patient Support in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tipsro.2023.100230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100230"}}